Fred Alger Management’s Moderna MRNA Stock Holding History

Fred Alger Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-190	Closed	-$23.1K	–	509
2023 Q2	$23.1K	Hold	190	–	–	﹤0.01%	487
2023 Q1	$29.2K	Sell	190 -204,363	-100%	-$33.7M	﹤0.01%	478
2022 Q4	$36.7M	Buy	+204,553	New	+$33.4M	0.2%	137
2021 Q4	–	Sell	-32,139	Closed	-$12.4M	–	540
2021 Q3	$12.4M	Sell	32,139 -66,680	-67%	-$24.6M	0.03%	225
2021 Q2	$23.2M	Buy	+98,819	New	+$17.7M	0.05%	202
2020 Q4	–	Sell	-269,077	Closed	-$19M	–	490
2020 Q3	$19M	Sell	269,077 -26,201	-9%	-$1.83M	0.06%	172
2020 Q2	$19M	Buy	295,278 +66,307	+29%	+$3.63M	0.06%	164
2020 Q1	$6.86M	Buy	+228,971	New	+$5.27M	0.03%	195
2019 Q4	–	Sell	-10,000	Closed	-$159K	–	506
2019 Q3	$159K	Buy	+10,000	New	+$148K	﹤0.01%	403
2019 Q2	–	Sell	-21,000	Closed	-$427K	–	541
2019 Q1	$427K	Buy	+21,000	New	+$390K	﹤0.01%	376

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Fred Alger Management's MRNA Position: Q3 2023 in Review

Fred Alger Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 190 shares — an estimated $23.1K sold.

Fred Alger Management first reported a position in MRNA in Q1 2019 and held it in 10 quarters. The position peaked at $36.7M in Q4 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

Fred Alger Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
Fred Alger Management sold 190 Moderna shares in Q3 2023, an estimated $23.1K.
Fred Alger Management first reported a position in Moderna in Q1 2019 and held it in 10 quarters.
Fred Alger Management's Moderna position peaked at $36.7M in Q4 2022.
889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Fred Alger Management's 13F filing for Q3 2023, filed 14 Nov 2023.